Articles Tagged With: bacteremia
-
ID Consultation Leads to Reduced Mortality from Gram-Negative Bacteremia
A multicenter, retrospective cohort study on patients with gram-negative bacteremia found infectious diseases consultation was associated with a 40% decrease in 30-day mortality.
-
Use of Ceftobiprole for Complicated Staphylococcus aureus Bacteremia
In a randomized, controlled trial conducted by Holland and colleagues, no significant difference in overall treatment success of complicated Staphylococcus aureus bacteremia was observed in patients who received ceftobiprole as compared with patients who received daptomycin.
-
Duration of Antibiotic Therapy for Carbapenem-Resistant Enterobacterales Bacteremia
This multicenter, observational study provides the first focused comparison of short vs. prolonged antibiotic courses for carbapenem-resistant Enterobacterales bloodstream infections, suggesting that short courses (eight to 10 days) have similar outcomes to prolonged courses.
-
What Is the Optimal Duration of Antibiotics for a Complicated UTI with Bacteremia?
An observational study of adults hospitalized with a complicated urinary tract infection and bacteremia revealed seven days of therapy was enough for most cases when they received antibiotics with comparable intravenous and oral bioavailability.
-
What Is the Optimal Duration of Antibiotics for a Complicated UTI with Bacteremia?
An observational study of adults hospitalized with a complicated urinary tract infection and bacteremia found seven days of therapy was enough for the majority of cases when they received antibiotics with comparable intravenous and oral bioavailability.
-
Immortal Time Bias and Mortality Effects of 18F-FDG-PET/CT in Patients with Staphylococcus aureus Bacteremia
Staphylococcus aureus bacteremia is associated with high mortality and often is complicated by metastatic sites of infection that can be difficult to identify and control. Fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography has shown promise in some observational studies as an important diagnostic modality for detecting foci of infection and potentially guiding clinical management in ways that may lead to improved outcomes, including lower mortality. The validity of these findings has been questioned, however, due to the risk of significant bias.
-
A Rapid Molecular Test Improves Time to Appropriate Therapy and Mortality in Patients with CRE Bacteremia
A multicenter observational study of patients with carbapenem-resistant Enterobacterales bacteremia found that time to receipt of active antibiotic therapy and mortality were improved in those whose blood cultures underwent rapid molecular testing for the Klebsiella pneumoniae carbapenemase gene. The mortality rate was 10% with ceftazidime-avibactam compared to 31% with polymyxin monotherapy.
-
Is There Value in Repeating Blood Cultures While the First Set Is Still Incubating?
The yield from repeat blood cultures is low, suggesting their general use in most patients should be discouraged.
-
Active Cancer and Staphylococcus aureus Bacteremia Is Associated with Less Risk for Infective Endocarditis
A multicenter cohort study found patients with S. aureus bacteremia (SAB) and active cancer were at a lower risk for infective endocarditis (IE) than those with SAB without cancer. Persistent bacteremia and cardiomyopathy were independent risk factors for IE.
-
IDWeek 2021: Skipping Along with Staphylococcus aureus
A single set of blood cultures may be inadequate to document clearance of Staphylococcus aureus bacteremia in some patients.